A fantastic collaboration on this milestone project. Congratulations to Xaria Li and Joshua Dent who led the work from the laboratories of Richard Clark and myself at UQ.
Our new tool: R8Y is the first selective full agonist for human C5aR2. ๐@FightMND for funding support.
Our new tool: R8Y is the first selective full agonist for human C5aR2. ๐@FightMND for funding support.
Delighted to share our paper on signaling-bias at the complement anaphylatoxin receptors now published in @MolecularCell! 1/nView quoted post on X
Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors: Molecular Cell cell.com/molecular-cellโฆ
